IL157597A0 - Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors - Google Patents

Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors

Info

Publication number
IL157597A0
IL157597A0 IL15759702A IL15759702A IL157597A0 IL 157597 A0 IL157597 A0 IL 157597A0 IL 15759702 A IL15759702 A IL 15759702A IL 15759702 A IL15759702 A IL 15759702A IL 157597 A0 IL157597 A0 IL 157597A0
Authority
IL
Israel
Prior art keywords
diaminoquinazoline
esters
reductase inhibitors
dihydrofolate reductase
dihydrofolate
Prior art date
Application number
IL15759702A
Other languages
English (en)
Original Assignee
Melacure Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100694A external-priority patent/SE0100694D0/xx
Priority claimed from SE0200008A external-priority patent/SE0200008D0/xx
Application filed by Melacure Therapeutics Ab filed Critical Melacure Therapeutics Ab
Publication of IL157597A0 publication Critical patent/IL157597A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15759702A 2001-02-28 2002-02-28 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors IL157597A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100694A SE0100694D0 (sv) 2001-02-28 2001-02-28 DHFR inhibitors
SE0200008A SE0200008D0 (sv) 2002-01-02 2002-01-02 New pharmaceutically compounds
PCT/GB2002/000888 WO2002068397A1 (en) 2001-02-28 2002-02-28 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors

Publications (1)

Publication Number Publication Date
IL157597A0 true IL157597A0 (en) 2004-03-28

Family

ID=26655401

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15759702A IL157597A0 (en) 2001-02-28 2002-02-28 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors

Country Status (9)

Country Link
US (1) US20040092515A1 (ja)
EP (1) EP1366028A1 (ja)
JP (1) JP2004520414A (ja)
KR (1) KR20030086272A (ja)
BR (1) BR0207706A (ja)
CA (1) CA2439463A1 (ja)
IL (1) IL157597A0 (ja)
MX (1) MXPA03007699A (ja)
WO (1) WO2002068397A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032807A1 (en) * 2003-08-06 2005-02-10 Rosenwald Lindsay A. Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives
AU2006334107A1 (en) * 2005-12-30 2007-07-12 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
WO2008020042A1 (en) * 2006-08-16 2008-02-21 Action Medicines, S.L. Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases
US7550674B2 (en) 2007-02-22 2009-06-23 Nexans UTP cable
SG176983A1 (en) 2009-07-08 2012-02-28 Dermira Canada Inc Tofa analogs useful in treating dermatological disorders or conditions
CN110719960B (zh) * 2017-03-23 2024-03-08 梅哈里医学院 用于诊断和治疗炎性肠病的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108630A0 (en) * 1993-02-18 1994-05-30 Fmc Corp Insecticidal substituted 2,4-diaminoquinazolines

Also Published As

Publication number Publication date
WO2002068397A1 (en) 2002-09-06
JP2004520414A (ja) 2004-07-08
BR0207706A (pt) 2004-03-23
US20040092515A1 (en) 2004-05-13
MXPA03007699A (es) 2004-03-16
WO2002068397A8 (en) 2003-12-04
KR20030086272A (ko) 2003-11-07
EP1366028A1 (en) 2003-12-03
CA2439463A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
ATE286049T1 (de) Pyridazinonaldose reductase inhibitoren
EG25482A (en) Inhibitors
PL363391A1 (en) Phthalayinone-piperidino-derivatives as pde4 inhibitors
EP1496910A4 (en) KINASE INHIBITORS
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003286711A1 (en) Indazolinone compositions useful as kinase inhibitors
IL157109A0 (en) Quinazolines as mmp-13 inhibitors
HK1066546A1 (en) Trifluoromethylpurines as phosphodiesterase 4 inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
ZA200510319B (en) 6-arylamino-5-cyano-4-pyrimidinones as PDE9a inhibitors
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
EP1558609A4 (en) KINASE INHIBITORS
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
AU2003272719A8 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
ZA200409686B (en) Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
EP1570847A4 (en) PHOSPHODIESTERASE 10A HEMMER
IL157597A0 (en) Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
AU2003244080A1 (en) Phosphodiesterase inhibitor
GB0001565D0 (en) Dihydrofolate reductase inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors